{
    "Trade/Device Name(s)": [
        "Immunalysis Buprenorphine Urine Enzyme Immunoassay",
        "Immunalysis Buprenorphine Urine Controls",
        "Immunalysis Buprenorphine Urine Calibrators"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K141406",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040316"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "July 1, 2014",
    "Summary Letter Received Date": "May 28, 2014",
    "Submission Date": "May 23, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Clinical Toxicology Calibrator",
        "Clinical Toxicology Control Materials"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "Norbuprenorphine",
        "Buprenorphine Glucuronide",
        "Norbuprenorphine Glucuronide"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Beckman Coulter AU 400e"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Buprenorphine Urine Enzyme Immunoassay, Controls, and Calibrators for qualitative and semi-quantitative detection of buprenorphine in urine using automated clinical chemistry analyzers.",
    "Indications for Use Summary": "Qualitative and semi-quantitative analysis of buprenorphine in human urine in laboratories with automated clinical chemistry analyzers; controls and calibrators used with the immunoassay for prescription use only.",
    "fda_folder": "Toxicology"
}